“This year may bring major changes in how artificial intelligence (AI) shapes the healthcare industry—and vice versa—and tempering hype for the technology with ensuring patient safety will be essential.
While the FDA has already handed down green lights to more than 1,000 different medical devices and pieces of software powered by AI and machine learning at last count, none of them so far have the ability to update their own programming and keep pace with new data. Their algorithms are locked once they head to the clinic, and they are designed to offer the same conclusion each time they are faced with the same input.
This article features Atropos Health CEO and Co-Founder Dr. Brigham Hyde discussing AI regulations and government initiatives in healthcare. Hyde shares his thoughts on how regulation in the space can be a positive and thoughtful endeavor.